These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23075174)

  • 21. Coming closer to FDA reform.
    Cimmons M
    Nat Med; 1997 Sep; 3(9):940. PubMed ID: 9288707
    [No Abstract]   [Full Text] [Related]  

  • 22. Shattuck lecture. Innovation, regulation, and the FDA.
    Hamburg MA
    N Engl J Med; 2010 Dec; 363(23):2228-32. PubMed ID: 21121835
    [No Abstract]   [Full Text] [Related]  

  • 23. Losing deference in the FDA's second century: judicial review, politics, and a diminished legacy of expertise.
    O'Reilly JT
    Cornell Law Rev; 2008 Jul; 93(5):939-80. PubMed ID: 18618965
    [No Abstract]   [Full Text] [Related]  

  • 24. Fifty Years of Expert Advice - Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study.
    Schwartz JL
    N Engl J Med; 2016 Nov; 375(21):2015-2017. PubMed ID: 27959733
    [No Abstract]   [Full Text] [Related]  

  • 25. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL
    Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
    [No Abstract]   [Full Text] [Related]  

  • 26. Bush tails follow-ons.
    Fox J
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392007
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmaceuticals and medical devices: FDA oversight.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-86. PubMed ID: 22403845
    [No Abstract]   [Full Text] [Related]  

  • 28. Caveat doctor.
    McCarthy M
    Lancet; 1999 Aug; 354(9177):446. PubMed ID: 10465167
    [No Abstract]   [Full Text] [Related]  

  • 29. New drug law to speed scientific review.
    Nature; 1992 Oct; 359(6396):563. PubMed ID: 1406977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceuticals and medical devices: FDA oversight.
    Berry MD
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-123. PubMed ID: 24482893
    [No Abstract]   [Full Text] [Related]  

  • 31. Ejecting the FDA from the courtroom.
    Lancet; 2004 Aug 21-27; 364(9435):638. PubMed ID: 15325808
    [No Abstract]   [Full Text] [Related]  

  • 32. The 50th anniversary of the Kefauver-Harris Amendments: efficacy assessment and the randomized clinical trial.
    Turner JR
    J Clin Hypertens (Greenwich); 2012 Nov; 14(11):810-5. PubMed ID: 23126358
    [No Abstract]   [Full Text] [Related]  

  • 33. Special patent provisions for pharmaceuticals: have they outlived their usefulness? A political, legislative and legal history of U.S. law and observations for the future.
    Engelberg AB
    Spec Law Dig Health Care Law; 2000 Sep; (258):9-48. PubMed ID: 11184791
    [No Abstract]   [Full Text] [Related]  

  • 34. Trouble at the office.
    Allison M
    Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
    [No Abstract]   [Full Text] [Related]  

  • 35. The FDA's accelerated approval process: does the pharmaceutical industry have adequate incentives for self-regulation?
    Orlando VI
    Am J Law Med; 1999; 25(4):543-68. PubMed ID: 10629734
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulatory considerations in the development of protein pharmaceuticals.
    Beatrice MG
    Pharm Biotechnol; 2002; 14():405-56. PubMed ID: 12189729
    [No Abstract]   [Full Text] [Related]  

  • 37. PDUFA reauthorization--drug safety's golden moment of opportunity?
    Hennessy S; Strom BL
    N Engl J Med; 2007 Apr; 356(17):1703-4. PubMed ID: 17435082
    [No Abstract]   [Full Text] [Related]  

  • 38. Understanding the Rewards of Successful Drug Development - Thinking Inside the Box.
    Khullar D; Ohn JA; Trusheim M; Bach PB
    N Engl J Med; 2020 Jan; 382(5):473-480. PubMed ID: 31995697
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA under pressure to relax drug rules.
    Ledford H
    Nature; 2012 Dec; 492(7427):19. PubMed ID: 23222585
    [No Abstract]   [Full Text] [Related]  

  • 40. The FDA: is it protecting the public with one hand tied behind its back?
    Shedlin RS
    Law Med Health Care; 1992; 20(3):253-7. PubMed ID: 1434771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.